Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction

Stefan James*, Sasha Koul, Jonas Andersson, Oskar Angerås, Pallonji Bhiladvala, Fredrik Calais, Mikael Danielewicz, Ole Fröbert, Per Grimfjärd, Matthias Götberg, Loghman Henareh, Dan Ioanes, Jens Jensen, Rikard Linder, Pontus Lindroos, Elmir Omerovic, Georgios Panayi, Truls Råmunddal, Giovanna Sarno, Anders UlvenstamSebastian Völtz, Henrik Wagner, Helena Wikström, Ollie Östlund, David Erlinge

*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science